T-cell receptor sequencing reveals selected donor-reactive CD8+ T cell clones resist antithymocyte globulin depletion after kidney transplantation

• Published in: American journal of transplantation Vol. 24; no. 5; pp. 755 - 764
• Main Authors: Ningoo, Mehek, Cruz-Encarnación, Pamela, Khilnani, Calla, Heeger, Peter S., Fribourg, Miguel
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2024
• Subjects: Adult; Animals; Antilymphocyte Serum - therapeutic use; CD4-Positive T-Lymphocytes - immunology; CD8-Positive T-Lymphocytes - immunology; Female; Follow-Up Studies; Graft Rejection - etiology; Graft Rejection - immunology; Graft Survival - immunology; Humans; Kidney Failure, Chronic - immunology; Kidney Failure, Chronic - surgery; Kidney Transplantation - adverse effects; Lymphocyte Depletion; Male; Middle Aged; Prognosis; Rabbits; Receptors, Antigen, T-Cell - genetics; Receptors, Antigen, T-Cell - metabolism; TCR repertoire; thymoglobulin; Tissue Donors; transplant; TCR; CTOT-19; thymoglobulin; PBMC; TCR repertoire; AR; IFN-γ; MLR; TCRseq; TCMR; rATG; Tac; transplant; HLA
• ISSN: 1600-6135; 1600-6143; 1600-6143
• DOI: 10.1016/j.ajt.2023.12.016

High frequencies of donor-reactive memory T cells in the periphery of transplant candidates prior to transplantation are linked to the development of posttransplant acute rejection episodes and reduced allograft function. Rabbit antithymocyte globulin (rATG) effectively depletes naïve CD4+ and CD8+ T cells for >6 months posttransplant, but rATG’s effects on human donor-reactive T cells have not been carefully determined. To address this, we performed T cell receptor β-chain sequencing on peripheral blood mononuclear cells aliquots collected pretransplant and serially posttransplant in 7 kidney transplant recipients who received rATG as induction therapy. We tracked the evolution of the donor-reactive CD4+ and CD8+ T cell repertoires and identified stimulated pretransplant, CTV-(surface dye)-labeled, peripheral blood mononuclear cells from each patient with donor cells or third-party cells. Our analyses showed that while rATG depleted CD4+ T cells in all tested subjects, a subset of donor-reactive CD8+ T cells that were present at high frequencies pretransplant, consistent with expanded memory cells, resisted rATG depletion, underwent posttransplant expansion and were functional. Together, our data support the conclusion that a subset of human memory CD8+ T cells specifically reactive to donor antigens expand in vivo despite induction therapy with rATG and thus have the potential to mediate allograft damage.